Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs

被引:27
作者
Gao, Jian [1 ,2 ]
Liang, Li [1 ]
Zhu, Yasheng [1 ]
Qiu, Shengzhi [1 ]
Wang, Tao [1 ]
Zhang, Ling [1 ]
机构
[1] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou 221004, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221004, Jiangsu, Peoples R China
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2016年 / 17卷 / 07期
关键词
peptide deformylase; pharmacophore model; high-throughput virtual screening; molecular docking; antibacterial drug; PSEUDOMONAS-AERUGINOSA; MOLECULAR DOCKING; DISCOVERY; DESIGN; GSK1322322; STRAINS; TARGET; AGENTS; GENES;
D O I
10.3390/ijms17071141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide deformylase (PDF) is a metalloprotease catalyzing the removal of a formyl group from newly synthesized proteins, which makes it an important antibacterial drug target. Given the importance of PDF inhibitors like actinonin in antibacterial drug discovery, several reported potent PDF inhibitors were used to develop pharmacophore models using the Galahad module of Sybyl 7.1 software. Generated pharmacophore models were composed of two donor atom centers, four acceptor atom centers and two hydrophobic groups. Model-1 was screened against the Zinc database and several compounds were retrieved as hits. Compounds with Qfit values of more than 60 were employed to perform a molecular docking study with the receptor Escherichia coli PDF, then compounds with docking score values of more than 6 were used to predict the in silico pharmacokinetic and toxicity risk via OSIRIS property explorer. Two known PDF inhibitors were also used to perform a molecular docking study with E. coli PDF as reference molecules. The results of the molecular docking study were validated by reproducing the crystal structure of actinonin. Molecular docking and in silico pharmacokinetic and toxicity prediction studies suggested that ZINC08740166 has a relatively high docking score of 7.44 and a drug score of 0.78.
引用
收藏
页数:10
相关论文
共 32 条
[1]  
[Anonymous], 2005, SYB 7 1
[2]   Art-175 Is a Highly Efficient Antibacterial against Multidrug-Resistant Strains and Persisters of Pseudomonas aeruginosa [J].
Briers, Yves ;
Walmagh, Maarten ;
Grymonprez, Barbara ;
Biebl, Manfred ;
Pirnay, Jean-Paul ;
Defraine, Valerie ;
Michiels, Jan ;
Cenens, William ;
Aertsen, Abram ;
Miller, Stefan ;
Lavigne, Rob .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) :3774-3784
[3]   Natural products - The future scaffolds for novel antibiotics? [J].
Butler, MS ;
Buss, AD .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (07) :919-929
[4]   Applications of structure-based design to antibacterial drug discovery [J].
Cain, Ricky ;
Narramore, Sarah ;
McPhillie, Martin ;
Simmons, Katie ;
Fishwick, Colin W. G. .
BIOORGANIC CHEMISTRY, 2014, 55 :69-76
[5]   Receptor-based virtual screening protocol for drug discovery [J].
Cerqueira, Nuno M. F. S. A. ;
Gesto, Diana ;
Oliveira, Eduardo F. ;
Santos-Martins, Diogo ;
Bras, Natercia F. ;
Sousa, Sergio F. ;
Fernandes, Pedro A. ;
Ramos, Maria J. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2015, 582 :56-67
[6]   Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor [J].
Chen, DZ ;
Patel, DV ;
Hackbarth, CJ ;
Wang, W ;
Dreyer, G ;
Young, DC ;
Margolis, PS ;
Wu, C ;
Ni, ZJ ;
Trias, J ;
White, RJ ;
Yuan, ZY .
BIOCHEMISTRY, 2000, 39 (06) :1256-1262
[7]   Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review [J].
Cheng, Tiejun ;
Li, Qingliang ;
Zhou, Zhigang ;
Wang, Yanli ;
Bryant, Stephen H. .
AAPS JOURNAL, 2012, 14 (01) :133-141
[8]   Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor [J].
Clements, JM ;
Beckett, RP ;
Brown, A ;
Catlin, G ;
Lobell, M ;
Palan, S ;
Thomas, W ;
Whittaker, M ;
Wood, S ;
Salama, S ;
Baker, PJ ;
Rodgers, HF ;
Barynin, V ;
Rice, DW ;
Hunter, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :563-570
[9]   The crystal structure of mitochondrial (type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms [J].
Fieulaine, S ;
Juillan-Binard, CL ;
Serero, A ;
Dardel, F ;
Giglione, C ;
Meinnel, T ;
Ferrer, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (51) :42315-42324
[10]   Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms [J].
Giglione, C ;
Serero, A ;
Pierre, M ;
Boisson, B ;
Meinnel, T .
EMBO JOURNAL, 2000, 19 (21) :5916-5929